NATIONAL VENTURE CAPITAL ASSOCIATION for NATIONAL VENTURE CAPITAL ASSOCIATION
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Banking BAN
Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203) Implementation of the JOBS Act Review of decimalization study by the SEC, required under the JOBS Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY BAKER | — |
| JENNIFER DOWLING | — |
| BOBBY FRANKLIN | — |
| KELLY SLONE | — |
Telecommunications TEC
HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA)
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY BAKER | — |
| JENNIFER DOWLING | — |
| BOBBY FRANKLIN | — |
| KELLY SLONE | — |
Copyright/Patent/Trademark CPT
HR 3309, the Innovation Act of 2013; S. 866, Patent Quality Improvement Act; S. 1013, Patent Abuse Reduction Act; S. 1612, Patent Litigation Integrity Act; S. 1720, Patent Transparency & Improvement Act; Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY BAKER | — |
| JENNIFER DOWLING | — |
| BOBBY FRANKLIN | — |
| KELLY SLONE | — |
Health Issues HCR
No bill #: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions; HR 4302, the Protecting Access to Medicare Act of 2014, Section 216, Improving Medicare Policies for Clinical Diagnostic Laboratory Tests. No bill #: Lobbied Congress on the integrity of FDA's Special Protocol Assessment (SPA) process.Requested Congress to have FDA review the SPA process. Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY BAKER | — |
| JENNIFER DOWLING | — |
| BOBBY FRANKLIN | — |
| KELLY SLONE | — |
Energy/Nuclear ENG
Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; HR 2609 FY 2015 Energy and Water Appropriations. Senate Finance Energy Tax Paper
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY BAKER | — |
| JENNIFER DOWLING | — |
| BOBBY FRANKLIN | — |
| KELLY SLONE | — |
Science/Technology SCI
Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act)
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY BAKER | — |
| JENNIFER DOWLING | — |
| BOBBY FRANKLIN | — |
| KELLY SLONE | — |
Taxation/Internal Revenue Code TAX
S.232/HR 1295 Medical Device Access and Innovation Protection Act: would repeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY BAKER | — |
| JENNIFER DOWLING | — |
| BOBBY FRANKLIN | — |
| KELLY SLONE | — |
Immigration IMM
HR 4178 American Entrepreneurship & Investment Act; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY BAKER | — |
| JENNIFER DOWLING | — |
| BOBBY FRANKLIN | — |
| KELLY SLONE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.